BioXcel Therapeutics, Inc.

BTAINASDAQHealthcare● Active

$1.09

$-0.02(-1.36%)

Market Cap$33656584

P/E Ratio—

52W High$8.08

52W Low$1.01

Avg Volume1.6M

Open$1.10

Beta0.32

Employees Ownership Insider Trades

BioXcel Therapeutics, Inc. (BTAI) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BTAI · as of Mar 27, 2026

Latest filing snapshot

-8-21.62%vs prior year

BioXcel Therapeutics, Inc. (BTAI) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-8

Growth % (1Y)

-21.62%

Revenue / Employee

$22.1K

Net Income / Employee

$-2.41M

Market Cap

$34M

BTAI Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-27	2025-12-31	29	-8	-21.62%
2025-03-28	2024-12-31	37	-37	-50.00%
2024-03-22	2023-12-31	74	-109	-59.56%
2023-03-16	2022-12-31	183	+94	+105.62%
2022-03-11	2021-12-31	89	+39	+78.00%
2021-03-12	2020-12-31	50	+26	+108.33%
2020-03-09	2019-12-31	24	+6	+33.33%
2019-03-12	2018-12-31	18	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BioXcel Therapeutics, Inc.YOU

29$34M #6

MAIA

MAIA Biotechnology, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BTAI peer comparison

About BTAI employees

BTAI Employees · Headcount

BioXcel Therapeutics, Inc. (BTAI) employee data is sourced from the annual SEC 10-K filing. As of 2025, BioXcel Therapeutics, Inc. had 29 full-time employees globally. Full-time employees only. Global consolidated headcount.

BioXcel Therapeutics, Inc. employs 29 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $22,138, reflecting the company's operational efficiency.

BioXcel Therapeutics, Inc.'s workforce decreased by 8 (21.62%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

BioXcel Therapeutics, Inc.'s revenue per employee of $22,138 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BTAI Employees · 5 questions

As of the latest SEC 10-K filing (2025), BioXcel Therapeutics, Inc. had 29 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

BioXcel Therapeutics, Inc. employee counthow many employees does BioXcel Therapeutics, Inc. haveBTAI total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-27